Showing results (21-30 of 97) with videos related to
Sort By:
Pageof 10
Preventive Medicine|January 29, 2024
Squamocolumnar junction visibility, age, and implications for cervical cancer screening programsKanan T Desai, Natasha Hansen, Ana-Cecilia Rodriguez, et al.Plos Pathogens|July 15, 2026
Longitudinal analysis of high-risk HPV infections reveals within-host viral genome changes over timeSambit K Mishra, Meredith Yeager, Chase W Nelson, et al.Journal of Lower Genital Tract Disease|December 27, 2005
Preparing digitized cervigrams for colposcopy research and education: determination of optimal resolution and compression parametersJose Jeronimo, Rodney Long, Leif Neve, et al.The Journal of Infectious Diseases|January 25, 2011
Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort studyNicole G Campos, Ana Cecilia Rodriguez, Philip E Castle, et al.Vaccine|June 11, 2008
Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated womenTroy J Kemp, Alfonso García-Piñeres, Roni T Falk, et al.The Journal of Experimental Medicine|April 6, 2005
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen lociMary Carrington, Sophia Wang, Maureen P Martin, et al.Journal of Clinical Microbiology|March 9, 2007
Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa RicaMahboobeh Safaeian, Rolando Herrero, Allan Hildesheim, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa RicaRaphael P Viscidi, Mark Schiffman, Allan Hildesheim, et al.Journal of the National Cancer Institute|October 15, 2010
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infectionsMahboobeh Safaeian, Carolina Porras, Mark Schiffman, et al.The Journal of Infectious Diseases|June 2, 2011
A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History StudyNicolas Wentzensen, Ana Cecilia Rodriguez, Raphael Viscidi, et al.Pageof 10